✦ LIBER ✦

A383 Bortezomib plus Thalidomide in Newly Diagnosed Myeloma

✍ Scribed by Chen, S; Wang, L; Jiang, B; Qiu, L; Li, Y; Zhong, Y; Gao, W

Book ID: 118629338
Publisher: CIG Media Group, LP.
Year: 2009
Tongue: English
Weight: 116 KB
Volume: 9
Category: Article
ISSN: 1557-9190
DOI: 10.1016/s1557-9190(11)70565-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bortezomib Plus Thalidomide for Newly Di

Bortezomib Plus Thalidomide for Newly Diagnosed Multiple Myeloma in China

✍ Shi-Lun Chen; Bin Jiang; Lu-Gui Qiu; Li Yu; Yu-Ping Zhong; Wen Gao 📂 Article 📅 2010 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 126 KB

Thalidomide plus dexamethasone for newly

Thalidomide plus dexamethasone for newly diagnosed myeloma

✍ Heather Lindsey 📂 Article 📅 2002 🏛 The Lancet 🌐 English ⚖ 51 KB

Bortezomib and thalidomide, a steroid fr

Bortezomib and thalidomide, a steroid free regimen in newly diagnosed patients with multiple myeloma

✍ Nilanjan Ghosh; Xiaobu Ye; Anna Ferguson; Carol Ann Huff; Ivan Borrello 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 167 KB

Optimising bortezomib in newly diagnosed

Optimising bortezomib in newly diagnosed multiple myeloma

✍ S Vincent Rajkumar 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 68 KB

(Bortezomib plus lenalidomide/thalidomid

(Bortezomib plus lenalidomide/thalidomide)- vs (bortezomib or lenalidomide/thalidomide)-containing regimens as induction therapy in newly diagnosed multiple myeloma: a meta-analysis of randomized controlled trials

✍ Wang, Anyou; Duan, Qiaohong; Liu, Xin; Ding, Kaiyang; Han, Yongsheng; Zhu, Weibo 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 777 KB

Bortezomib in combination with dexametha

Bortezomib in combination with dexamethasone and subsequent thalidomide for newly-diagnosed multiple myeloma: A Chinese experience

✍ Weiyan Zheng; Guoqing Wei; Xiujin Ye; Jingsong He; Li Li; Wenjun Wu; Jimin Shi; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 245 KB

## Objective: Bortezomib-dexamethasone-thalidomide has been reported to be effective in newly-diagnosed multiple myeloma (mm) with an overall response rate of 92% and a cr rate of 18% (alexanian et al, hematology 2007;12(3):235-9), but this regimen has not been tested in the chinese patients. we re